SCHEMBL17876268

SCHEMBL17876268

c1ccc(N2Cc3cc(-c4cc(-c5cccnc5)cc(-c5cccnc5)c4)ccc3-c3cc(-c4ccc5oc6ccccc6c5c4)ccc3C2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 6/20 0.37
CYP11B2 P19099 6/20 0.37
CYP1A2 P05177 5/20 0.37
TDP2 O95551 2/20 0.37
PIM1 P11309 2/20 0.36
PIM2 Q9P1W9 2/20 0.36
PIM3 Q86V86 1/20 0.36
CYP3A4 P08684 5/20 0.36
LMNA P02545 2/20 0.36
MAPK1 P28482 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX15 P16050 1/20 0.36
KMT2A Q03164 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
BTK Q06187 3/20 0.35
PIK3CD O00329 2/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CB P42338 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876245 1.00 CYP11B1 (0.37) CYP11B1CYP11B2CYP1A2TDP2PIM1
SCHEMBL17876304 0.96 PIM1 (0.38) CYP11B1CYP11B2CYP1A2TDP2PIM1
SCHEMBL17876266 0.94 CYP11B1 (0.37) CYP11B1CYP11B2CYP1A2TDP2PIM1
SCHEMBL17876240 0.94 CYP11B1 (0.37) CYP11B1CYP11B2CYP1A2TDP2PIM1
SCHEMBL17876298 0.90 CYP11B1 (0.38) CYP11B1CYP11B2CYP1A2TDP2PIM1
SCHEMBL17876248 0.90 PRKDC (0.39) TDP2MAPK1MEN1ALDH1A1KMT2A
SCHEMBL17876260 0.90 PRKDC (0.39) TDP2MAPK1MEN1ALDH1A1KMT2A
SCHEMBL17876255 0.90 CYP11B1 (0.36) CYP11B1CYP11B2CYP1A2TDP2PIM1
SCHEMBL17876269 0.90 CYP11B1 (0.36) CYP11B1CYP11B2CYP1A2TDP2PIM1
SCHEMBL17876235 0.89 ALOX5 (0.39) CYP11B1CYP11B2CYP1A2TDP2PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885CYP1A2 757/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885CYP1A2 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.